seizure - Nursing Case Study

Pathophysiology

• Primary mechanism: Seizures result from abnormal, excessive electrical discharges in the brain's cortical neurons, often due to an imbalance between excitatory neurotransmitter glutamate and inhibitory neurotransmitter GABA, leading to hyperexcitability and neuronal synchronization.

• Secondary mechanism: Alterations in ion channels, particularly sodium and calcium channels, can exacerbate neuronal excitability by disrupting normal ion flow, further destabilizing membrane potentials and propagating uncontrolled neuronal firing.

• Key complication: Prolonged seizures, or status epilepticus, increase the risk of cerebral hypoxia, potentially leading to irreversible neuronal damage and severe neurological deficits if not promptly managed.

Patient Profile

Demographics:

45-year-old male, electrical engineer

History:

• Key past medical history: Long-standing epilepsy diagnosed at age 20, hypertension, type 2 diabetes, previous stroke at age 40

• Current medications: Phenytoin 300 mg daily, Lisinopril 20 mg daily, Metformin 1000 mg twice daily, Aspirin 81 mg daily

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Recurrent seizures over the past 24 hours

• Key symptoms: Prolonged periods of confusion post-seizure, severe headache, weakness on right side, difficulty speaking

• Vital signs: Blood pressure 180/110 mmHg, heart rate 110 beats per minute, respiratory rate 22 breaths per minute, temperature 99.6°F, oxygen saturation 88% on room air

Section 1

During the initial assessment, the clinical team observes a 45-year-old male in moderate distress, displaying signs of postictal confusion and right-sided hemiparesis. He is intermittently responsive to verbal stimuli but struggles to articulate coherent sentences, exhibiting expressive aphasia. Neurological examination reveals diminished strength (2/5) and decreased sensation on the right side. The patient's pupils are equal and reactive to light, but there is noted dysconjugate gaze suggesting possible involvement of the brainstem or cranial nerves. Given the history of prolonged seizures and current presentation, the team suspects status epilepticus with potential progression to non-convulsive status epilepticus, a condition that requires immediate intervention to prevent further neuronal injury.

Laboratory investigations are initiated, revealing a phenytoin level of 6 mcg/mL, significantly below the therapeutic range (10-20 mcg/mL), indicating subtherapeutic dosing potentially contributing to seizure recurrence. Blood glucose levels are elevated at 320 mg/dL, suggesting poor glycemic control that may exacerbate cerebral edema and neuronal excitability. Electrolyte analysis shows mild hyponatremia at 130 mmol/L, a potential consequence of chronic medication use and a further contributing factor to seizure activity. Arterial blood gas analysis highlights a respiratory acidosis with pH 7.30, pCO2 52 mmHg, pO2 75 mmHg, and HCO3 23 mmol/L, indicating hypoventilation and inadequate respiratory compensation, likely secondary to prolonged seizure activity and reduced consciousness.

The clinical team prioritizes stabilizing the patient's condition, initiating high-flow oxygen therapy to address hypoxia and considering intravenous benzodiazepines for rapid seizure control. Concurrently, an urgent MRI is ordered to assess for any acute intracranial changes, such as hemorrhage or significant edema. The patient is also started on an intravenous phenytoin loading dose to quickly achieve therapeutic drug levels. These interventions aim to mitigate immediate neurological threats while carefully monitoring for potential complications such as aspiration pneumonia, cardiac arrhythmias, or further neurological deterioration. The team's next steps involve a reassessment of the patient's response to treatment and consideration of advanced imaging and consultation with neurology for ongoing management.

Section 2

Following initial interventions, the clinical team closely monitors the patient's response to treatment. Despite administration of high-flow oxygen and intravenous benzodiazepines, the patient exhibits only partial improvement in responsiveness, with persistent postictal confusion and expressive aphasia. A repeat neurological examination reveals unchanged right-sided hemiparesis and continued dysconjugate gaze, raising concerns about ongoing seizure activity or secondary neurological insult. Vital signs remain stable with a blood pressure of 140/85 mmHg, heart rate of 98 bpm, respiratory rate of 22 breaths per minute, and oxygen saturation at 94% on supplemental oxygen.

New diagnostic results from the urgent MRI reveal diffuse cortical edema, particularly pronounced in the left hemisphere, correlating with the patient's right-sided deficits. There are no signs of acute intracranial hemorrhage, but the imaging suggests possible non-convulsive status epilepticus with secondary brainstem involvement. Concurrently, an electroencephalogram (EEG) is performed, confirming continuous epileptiform activity indicative of non-convulsive status epilepticus. This finding necessitates an urgent escalation in the patient's antiepileptic management, considering the potential for further neuronal damage and the risk of progression to refractory status epilepticus.

In response to these new findings, the clinical team decides to initiate a continuous infusion of midazolam, titrating the dose to achieve burst suppression on EEG. Additionally, given the patient's elevated blood glucose, an insulin infusion is started to achieve better glycemic control, aiming to reduce metabolic demands on the compromised brain. Ongoing evaluation focuses on preventing complications such as aspiration pneumonia, particularly given the patient's reduced consciousness and protective reflexes. The team also plans for a potential therapeutic hypothermia protocol to minimize cerebral edema and protect against ischemic injury, pending stabilization of the patient's cardiorespiratory status. These steps underscore the necessity of coordinated, multi-disciplinary care in managing this complex and evolving clinical scenario.

Section 3

Response to interventions:

Following the initiation of a continuous midazolam infusion, the clinical team observes a gradual reduction in epileptiform activity on the EEG, indicating a partial response to the intervention. However, the patient's clinical condition remains tenuous. Despite efforts to achieve burst suppression, the EEG reveals intermittent breakthrough seizures. Concomitantly, the patient's neurological examination remains largely unchanged, with persistent right-sided hemiparesis and expressive aphasia. A slight improvement is noted in the patient's level of consciousness, although she continues to exhibit significant postictal confusion. The team is encouraged by the stabilization of vital signs, with blood pressure holding steady at 135/80 mmHg, heart rate at 92 bpm, respiratory rate at 20 breaths per minute, and oxygen saturation improved to 96% on high-flow oxygen. Nevertheless, the patient's Glasgow Coma Scale (GCS) score remains low at 9, warranting continued intensive monitoring.

The initiation of insulin therapy has yielded a positive impact on metabolic control, with the patient's blood glucose levels decreasing from 280 mg/dL to a more favorable 170 mg/dL. Despite this progress, the multidisciplinary team remains vigilant for potential complications. Laboratory results reveal a slight increase in serum lactate levels, now at 2.5 mmol/L, suggesting ongoing metabolic stress. In light of the patient's reduced consciousness and impaired airway protective reflexes, the team has prophylactically initiated broad-spectrum antibiotics to mitigate the risk of aspiration pneumonia. Although therapeutic hypothermia has not yet been implemented due to the need for further cardiorespiratory stabilization, the team continues to evaluate this option.

As the clinical team strategizes the next steps, they consider the possibility of transitioning to additional antiepileptic agents, such as levetiracetam or valproate, to enhance seizure control. The persistent neurological deficits and ongoing seizure activity underscore the need for a dynamic and adaptive care plan. The team is also preparing for potential consultations with neurology and critical care specialists to optimize treatment strategies. This phase of the patient's care highlights the complexity of managing refractory non-convulsive status epilepticus and the critical importance of comprehensive, interdisciplinary collaboration in the intensive care setting.

Section 4

New complications have emerged in the patient's clinical course, necessitating immediate attention and advanced critical thinking from the multidisciplinary team. Despite the initial stabilization of vital signs, the patient exhibits a sudden and concerning decline in respiratory function. Her respiratory rate has increased to 28 breaths per minute, with oxygen saturation dropping to 90% despite continued high-flow oxygen support. Auscultation reveals diffuse crackles bilaterally, raising suspicion for the development of acute respiratory distress syndrome (ARDS) potentially secondary to aspiration or systemic inflammation. A chest X-ray confirms bilateral infiltrates, consistent with ARDS, complicating her already precarious clinical status.

Concurrently, the patient's renal function shows signs of deterioration. Serum creatinine has risen from 1.0 mg/dL to 1.8 mg/dL, and urine output has decreased significantly, indicating the onset of acute kidney injury (AKI). This renal compromise, coupled with the elevated serum lactate level now at 3.0 mmol/L, suggests a worsening of metabolic stress and potential multi-organ dysfunction. The team is faced with the challenge of managing these complications without exacerbating the patient's neurological condition. Fluid management becomes a delicate balance to address the AKI while avoiding fluid overload that could further impair respiratory status.

As the team deliberates on the next steps, they must consider the initiation of renal replacement therapy and the possibility of intubation and mechanical ventilation to support respiratory function. The complexity of the case underscores the need for ongoing interdisciplinary collaboration, with input from nephrology and pulmonology specialists. These developments highlight the critical importance of dynamic, adaptive strategies in the intensive care setting to navigate the intricate interplay of neurological, respiratory, and renal challenges in this critically ill patient.

Section 5

As the multidisciplinary team continues to navigate the complexities of the patient's condition, a change in her status prompts immediate reassessment and action. The patient's neurological status deteriorates further; she becomes increasingly lethargic and unresponsive to verbal stimuli, raising concerns about the potential progression of her underlying neurological injury or possible secondary insult. Her pupils are sluggishly reactive, and she exhibits decerebrate posturing in response to painful stimuli, suggesting worsening intracranial pressure or cerebral edema. In response, the neurology team urgently reassesses her need for an updated CT scan of the brain to evaluate for any acute changes such as hemorrhage or worsening edema that might be contributing to her declining neurological function.

Simultaneously, laboratory results reveal a further rise in serum creatinine to 2.5 mg/dL, confirming the progression of acute kidney injury. This renal deterioration necessitates a delicate recalibration of fluid management strategies. The nephrology team recommends the initiation of continuous renal replacement therapy (CRRT) to manage fluid balance and support renal function without compromising hemodynamics. However, concerns about potential hypotension during CRRT necessitate careful hemodynamic monitoring and possible vasopressor support.

The critical nature of the patient's respiratory status also demands urgent attention. Despite high-flow oxygen, her oxygen saturation drops further to 85%, and her work of breathing increases significantly. The decision is made to intubate and initiate mechanical ventilation to stabilize her respiratory function. The pulmonology team devises a lung-protective ventilation strategy tailored to manage her ARDS, considering her fragile neurological status. This includes low tidal volume and appropriate positive end-expiratory pressure (PEEP) to optimize oxygenation while minimizing potential barotrauma. As these interventions are implemented, the team remains vigilant for new complications, continuously evaluating the intricate balance between treating her systemic issues and safeguarding her neurological recovery.